Zealand Pharma A/S (ZLDPF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Zealand Pharma A/S's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
5.09
Strong
WeakModerateStrong
P/B Ratio
2.22
Strong
WeakModerateStrong
Earnings Yield
19.63%
Strong
WeakModerateStrong
Profitability Health
2025Return on Equity
43.52%
Strong
WeakModerateStrong
Operating Margin
77.66%
Strong
WeakModerateStrong
Net Profit Margin
70.05%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
14565.56%
Strong
WeakModerateStrong
Net Income Growth
696.98%
Strong
WeakModerateStrong
EPS Growth
662.68%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
23.57
Strong
WeakModerateStrong
Quick Ratio
23.57
Strong
WeakModerateStrong
Asset Turnover
0.56x
Moderate
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
19.76%
Strong
WeakModerateStrong
EV / Free Cash Flow
4.42x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.58x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.978
Strong
WeakModerateStrong
Return on Invested Capital
41.71%
Strong
WeakModerateStrong
Cash Conversion Cycle
-3311.52 days
Strong
WeakModerateStrong
Fortress screener guardrails
4/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ZLDPF.
View Financial Statements